v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 37,648,797 $ 28,417,310
Short-term investments 10,067,886
Tax incentive and other receivables 933,250
Prepaid expenses 636,015 834,479
Total current assets 49,285,948 29,251,789
Total assets 49,285,948 29,251,789
Current liabilities:    
Accounts payable 3,432,161 260,613
Accrued expenses and other current liabilities 6,261,309 2,293,643
Total current liabilities 9,693,470 2,554,256
Total liabilities 12,686,523 5,496,524
Commitments and contingencies (Note 4)
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, and no shares issued and outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.0001 par value, 300,000,000 shares authorized; 32,198,214 and 27,198,214 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 4,720 2,720
Related party note receivable (4,124,274) (4,065,096)
Additional paid-in capital 85,734,267 66,630,765
Accumulated deficit (45,015,288) (38,813,124)
Total stockholders’ equity 36,599,425 23,755,265
Total liabilities and stockholders’ equity 49,285,948 29,251,789
Related Parties    
Current liabilities:    
Notes payable – related parties $ 2,993,053 $ 2,942,268